Livongo Health Inc
Change company Symbol lookup
Select an option...
LVGO Livongo Health Inc
SJMiv.P Invesco BulletShares 2022 Hi Yld Corp Bd ETF
INTC Intel Corp
AAPL Apple Inc
VAL Valaris PLC
GE General Electric Co
XOM Exxon Mobil Corp
MSFT Microsoft Corp
AMZN Amazon.com Inc
NFLX Netflix Inc
Go

Company profile

Livongo Health, Inc. is a consumer digital health company. The Company offers Enter Livongo platform, which leverages data science and technology, creates a personalized experience for people with chronic conditions. The Company focuses on developing an approach for diabetes management that combines technology with coaching. The Company’s Livongo platform offers a range of solutions, such as Livongo for Diabetes, Livongo for Hypertension, Livongo for Prediabetes and Weight Management and Livongo for Behavioral Health by myStrength. The Company uses a digital approach to delivering evidence-based interventions including cognitive behavioral therapy, acceptance and commitment therapy, positive psychology, mindfulness, and motivational interviewing to help resolve clinical conditions, build resiliency, manage stress, improve mood, sleep better, or simply find daily inspiration.

Closing Price
$27.43
Day's Change
-0.58 (-2.07%)
Bid
--
Ask
--
B/A Size
--
Day's High
28.30
Day's Low
27.11
Volume
(Below Average)
Volume:
458,986

10-day average volume:
515,160
458,986

Roku makes ad-tech acquisition of dataxu

11:53 am ET October 22, 2019 (MarketWatch)
Print

Roku Inc. (ROKU) announced Tuesday that it has agreed to purchase dataxu, a Boston-based advertising technology company, for $150 million in cash and stock. The dataxu platform gives marketers the ability to conduct bidding, place self-serve ads, and manage campaigns. Roku said in a release that the deal will give the company the ability to offer marketers one "data-driven software solution to plan, buy, and optimize their ad spend across TV and OTT providers." Shares were off 0.3% in midday trading Tuesday as the S&P 500 was up 0.2%. Roku's stock has vastly outperformed the S&P 500 this year, rising 332% over 2019, compared with a 20% gain for the index.

-Emily Bary; 415-439-6400; AskNewswires@dowjones.com

(END) Dow Jones Newswires

October 22, 2019 11:53 ET (15:53 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.